Home/Filings/4/0000899243-21-005161
4//SEC Filing

Third Rock Ventures III, L.P. 4

Accession 0000899243-21-005161

CIK 0001549595other

Filed

Feb 7, 7:00 PM ET

Accepted

Feb 8, 4:11 PM ET

Size

17.4 KB

Accession

0000899243-21-005161

Insider Transaction Report

Form 4
Period: 2021-02-04
Transactions
  • Other

    Common Stock

    2021-02-04914,2164,508,333 total
Holdings
  • Common Stock

    (indirect: See footnote)
    41,008
  • Common Stock

    (indirect: See footnote)
    45,564
  • Common Stock

    (indirect: See footnote)
    4,554
  • Common Stock

    (indirect: See footnote)
    45,565
LEVIN MARK J
10% Owner
Transactions
  • Other

    Common Stock

    2021-02-04914,2164,508,333 total
Holdings
  • Common Stock

    (indirect: See footnote)
    45,565
  • Common Stock

    (indirect: See footnote)
    41,008
  • Common Stock

    (indirect: See footnote)
    4,554
  • Common Stock

    (indirect: See footnote)
    45,564
Transactions
  • Other

    Common Stock

    2021-02-04914,2164,508,333 total
Holdings
  • Common Stock

    (indirect: See footnote)
    41,008
  • Common Stock

    (indirect: See footnote)
    45,565
  • Common Stock

    (indirect: See footnote)
    4,554
  • Common Stock

    (indirect: See footnote)
    45,564
Transactions
  • Other

    Common Stock

    2021-02-04914,2164,508,333 total
Holdings
  • Common Stock

    (indirect: See footnote)
    41,008
  • Common Stock

    (indirect: See footnote)
    45,565
  • Common Stock

    (indirect: See footnote)
    4,554
  • Common Stock

    (indirect: See footnote)
    45,564
STARR KEVIN P
10% Owner
Transactions
  • Other

    Common Stock

    2021-02-04914,2164,508,333 total
Holdings
  • Common Stock

    (indirect: See footnote)
    41,008
  • Common Stock

    (indirect: See footnote)
    45,565
  • Common Stock

    (indirect: See footnote)
    4,554
  • Common Stock

    (indirect: See footnote)
    45,564
Transactions
  • Other

    Common Stock

    2021-02-04914,2164,508,333 total
Holdings
  • Common Stock

    (indirect: See footnote)
    41,008
  • Common Stock

    (indirect: See footnote)
    4,554
  • Common Stock

    (indirect: See footnote)
    45,565
  • Common Stock

    (indirect: See footnote)
    45,564
Footnotes (6)
  • [F1]On February 4, 2021, Third Rock Ventures III, L.P. ("TRV III") distributed for no consideration, 914,216 shares of Common Stock of the Issuer (the "Shares") to its limited partners and to Third Rock Ventures GP III, L.P. ("TRV GP III"), the general partner of TRV III, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP III distributed, for no consideration, the Shares it received in the distribution by TRV III to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended.
  • [F2]These shares are directly held by TRV III. The general partner of TRV III is TRV GP III. The general partner of TRV GP III is TRV GP III, LLC ("TRV GP III LLC"). The individual managers of TRV GP III LLC are Mark Levin ("Levin"), Kevin Starr ("Starr") and Dr. Robert Tepper ("Tepper"). Each of TRV GP III, TRV GP III LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares.
  • [F3]The shares are directly held by Levin. Includes Shares received in the distributions described in footnote (1) above.
  • [F4]The shares are directly held by Levin Family 2014 Irrevocable Trust. Includes Shares received in the distributions described in footnote (1) above.
  • [F5]The shares are directly held by Starr. Includes Shares received in the distributions described in footnote (1) above.
  • [F6]The shares are directly held by Tepper. Includes Shares received in the distributions described in footnote (1) above.

Issuer

Nurix Therapeutics, Inc.

CIK 0001549595

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001569705

Filing Metadata

Form type
4
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 4:11 PM ET
Size
17.4 KB